Discussion

Title: KY1043, a novel CD25-directed PD-L1 IL-2 immunocytokine, delivers potent anti-tumor activity in vivo via an expansion of a Tcf1hi PD-1+ CD8+ T cell population
Presenter: Miha Kosmac
Enter your comments

You could not be found. Your status is Anonymous. Please log in at the AACR portal if you wish to place personal comments.
Previous comments
No Discussion started yet.